WE@HealthTech
Manuela Vecsler, PhD, currently serves as the Vice President of Clinical & Scientific Affairs at Ibex Medical Analytics since July 2019 and is a member of WE@HealthTech from May 2023. Previously, Manuela held the role of Senior Scientist and Regulatory & Clinical Affairs Lead at Betalin Therapeutics Ltd. and garnered extensive experience in clinical research and molecular genetics through various positions, including Post Doctoral Scientist at Bar Ilan University and Clinical Research Associate at Sheba - Tel Ha Shomer Hospital. Manuela's educational background includes a PhD in Molecular Genetics and Biochemistry from Tel Aviv University, an MSc in Human Genetics, and a D.M.D in Dental Medicine. Additionally, Manuela has contributed to the field through presentations at scientific conferences and has managed collaborations across academic and commercial settings.
WE@HealthTech
Women comprise about 70% of the HealthTech industry work force. Out of the 30 companies listed in the Biomed Index there are only two women CEOs amongst a total of sixty CEOs and Chairmen. The share value of companies that include women on their boards are higher by an average of 44% (Goldman Sachs). FORTUNE 500 companies with a larger number of women in senior management positions have better financial results (Catalyst). It follows that proper representation of women in top managerial levels will serve not only social and gender equality goals, but also organizational, business, and economic goals and performance. In partnership with 8400 we introduce a HealthTech launchpad program to promote junior women managers to executive positions throughout the ecosystem.